RxDoctor Payments Data

Erin Hatcher

Psychiatric/Mental Health · Marshalltown, IANPI 1679669832

Payments from drug & device makers

$1,280in general payments, 2019–2025

Across 72 payments — averaging $17.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$208
  • Otsuka America Pharmaceutical, Inc.$125
  • Alkermes, Inc.$125
  • Corium, LLC$114
  • AbbVie$102
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$84
  • plus $523 from 13 others

What the payments were for

  • Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,280 in reported general payments places this provider in the 60th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$23,078
Medicare patients
84
Services billed
503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate19$161,388
VraylarCariprazine Hcl70$103,025
Invega SustennaPaliperidone Palmitate35$100,039
Abilify MaintenaAripiprazole23$71,171
SpravatoEsketamine Hcl29$70,976
TrintellixVortioxetine Hydrobromide79$40,663
Ritalin LaMethylphenidate Hcl14$22,463
Aripiprazole155$14,339
Clozapine100$12,468
Bupropion XlBupropion Hcl348$6,449
Methylphenidate ErMethylphenidate Hcl27$5,996
VyvanseLisdexamfetamine Dimesylate15$5,622
LexaproEscitalopram Oxalate12$5,409
Ziprasidone Hcl101$4,936
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine64$4,484

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna, Spravato$208$332,40383 claims
AbbVieVraylar, Lexapro$102$108,43482 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$125$71,17123 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$37$46,28594 claims
Almatica Pharma LLCSertraline Hcl$41$1,302181 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Marshalltown

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →